Retatrutide is a new medication (still in development and not FDA-approved for treatment at this stage) that holds promise for helping people manage obesity and other related health issues
Honda, Y., Kessoku, T., Sumida, Y., Kobayashi, T., Kato, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Kataoka, K., Taguri, M., Yamanaka, T., Seko, Y., Tanaka, S., Saito, S., Ono, M., Oeda, S., Eguchi, Y
Chronic inflammation, on the other hand, is associated with conditions like type 2 diabetes, metabolic syndrome, obesity, cancer, arthritis, and bowel diseases like Crohns disease and ulcerative colitis (2)
doi: 10.3389/fendo.2021.735019 79 LazzaroniEBen NasrMLoretelliCPastoreIPlebaniLLunatiMEet al